Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000527.5(LDLR):c.1486_1487delGG(p.Gly496HisfsTer39) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
MIR6886 (HGNC:50121): (microRNA 6886) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-11113660-TGG-T is Pathogenic according to our data. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-11113660-TGG-T is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 222689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research
- -
Mar 11, 2015
Blueprint Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial hypercholesterolemiaPathogenic:1
Apr 12, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ClinVar contains an entry for this variant (Variation ID: 222689). This sequence change creates a premature translational stop signal (p.Gly496Hisfs*39) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with familial hypercholesterolemia (PMID: 11810272). This variant is also known as 1486delGG or the Surinam allele. For these reasons, this variant has been classified as Pathogenic. -